Publication dates

All regions

Therapy Industry, September 2014 Market Reports from Top Publishers

You might be interested in: therapeutics, medical equipment, drug, more »


 
1-10 of about 200 reports for Therapy

U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc.

  • $ 55
  • Company report
  • September 2014
  • by Wright Investors' Service

... For u.S. Physical therapy, inc. Are the company description, recent stock performance, profitability analysis, dividend analysis, and key data items (ticker, major industry, sub-industry, fiscal year end ...

ObeTherapy Biotechnology - Product Pipeline Review - 2014

ObeTherapy Biotechnology - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

... Latest company statement - latest news and deals relating to the obetherapy biotechnology's pipeline productsreasons to buy- evaluate obetherapy biotechnology's strategic ...

Asia-Pacific Infusion Therapy Device Market

Asia-Pacific Infusion Therapy Device Market

  • $ 7 995
  • Industry report
  • September 2014
  • by iData Research, Inc.

... Their penetration into the asia-pacific markets, the overall market value is expected to increase as well. Asia-pacific infusion therapy device market table of contentslist of figureslist of charts ...

Asia-Pacific Infusion Therapy Device Market - Executive Summary

Asia-Pacific Infusion Therapy Device Market - Executive Summary

  • $ 295
  • Industry report
  • September 2014
  • by iData Research, Inc.

... Their penetration into the asia-pacific markets, the overall market value is expected to increase as well. Asia-pacific infusion therapy device market - executive summary ...

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

... In this section, including the september 5, 2014 approval of merck's pd-1 inhibitor: pembrolizumab (keytr), as well as the future outlook of potential combination checkpoint inhibitor therapies. ...

Immunovative Therapies, Ltd. - Product Pipeline Review - 2014

Immunovative Therapies, Ltd. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • August 2014
  • by Global Markets Direct

... Summarizes all the dormant and discontinued pipeline projects- latest company statement - latest news and deals relating to the immunovative therapies, ltd.'S pipeline productsreasons to buy ...

Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2014

Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • August 2014
  • by Global Markets Direct

... The report summarizes all the dormant and discontinued pipeline projects- latest company statement - latest news and deals relating to the intra-cellular therapies, inc.'S pipeline products ...

Tissue Therapies Ltd

Tissue Therapies Ltd

  • $ 55
  • Company report
  • August 2014
  • by Wright Investors' Service

... Tissue therapies ltd a textual analysis of the financial results for tissue therapies ltd compared to selected competitors. Also included are quantitative analyses of the company's financial ...

Biotie Therapies Corp. (Symbol:BTH1V) SWOT Analysis, Strategy, Revenues and Profits

Biotie Therapies Corp. (Symbol:BTH1V) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Such as swot analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Biotie therapies corp. (Bth1v) - financial ...

OncoTherapy Science, Inc. (Symbol:4564) SWOT Analysis, Strategy, Revenues and Profits

OncoTherapy Science, Inc. (Symbol:4564) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Such as swot analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Oncotherapy science, inc. (4564) - Financial ...

About 21 000 reports for Therapy

Download Unlimited Documents from Trusted Public Sources

Radiation Therapy market structure in the US

  • Radiation Therapy in Stage Ii and Iii Rectal Cancer
  • September 2014
    7 pages
  • Radiation Thera...  

  • United States  

View report >

4 Companies for Therapy

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Abbott Laboratories

United States

Primary Sources

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.